Have a personal or library account? Click to login
The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma Cover

The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma

Open Access
|Oct 2020

Figures & Tables

Association between selected polymorphisms and the risk of developing malignant mesothelioma compared to pleural plaques

SNPGenotypePleural plaques N (%)MM N (%)OR (95 % CI)pOR (95 % CI)adj1padj1OR (95 % CI)adj2padj2
IL1B rs1143623GG205 (52.0)152 (54.9)referencereference
GC157 (39.8)97 (35.0)0.83 (0.60–1.16)0.2770.88 (0.61–1.27)0.4990.67 (0.39–1.15)0.151
CC32 (8.1)28 (10.1)1.18 (0.68–2.04)0.5541.07 (0.58–1.99)0.8270.65 (0.22–1.86)0.418
GC+CC189 (48.0)125 (45.1)0.89 (0.66–1.21)0.4670.92 (0.65–1.29)0.6170.67 (0.40–1.11)0.123
IL1B rs16944TT50 (12.7)36 (13.0)1.02 (0.63–1.67)0.9230.96 (0.56–1.67)0.8970.54 (0.22–1.34)0.184
TC169 (42.9)118 (42.6)0.99 (0.71–1.38)0.9690.98 (0.68–1.42)0.9290.70 (0.41–1.19)0.186
CC175 (44.4)123 (44.4)referencereference
TC+TT219 (55.6)154 (55.6)1.00 (0.73–1.36)0.9980.98 (0.69–1.38)0.9050.66 (0.40–1.10)0.110
IL1B rs1071676GG233 (59.1)165 (59.6)referencereference
GC145 (36.8)98 (35.4)0.95 (0.69–1.32)0.7780.93 (0.65–1.34)0.7080.92 (0.53–1.60)0.774
CC16 (4.1)14 (5.1)1.24 (0.59–2.60)0.5781.29 (0.56–2.97)0.5532.83 (1.04–7.71)0.042
GC+CC161 (40.9)112 (40.4)0.98 (0.72–1.34)0.9110.97 (0.68–1.37)0.8491.09 (0.66–1.82)0.731
MIR146A rs2910164GG196 (49.7)158 (57.0)referencereference
GC163 (41.4)110 (39.7)0.84 (0.61–1.15)0.2760.84 (0.58–1.20)0.3260.65 (0.38–1.11)0.118
CC35 (8.9)9 (3.2)0.32 (0.15–0.68)0.0030.33 (0.15–0.75)0.0080.34 (0.11–1.09)0.069
GC+CC198 (50.3)119 (43.0)0.75 (0.55–1.02)0.0630.74 (0.53–1.05)0.0920.59 (0.36–0.99)0.046

Characteristics of subjects included in the study

CharacteristicsControl group N = 175Pleural plaques N = 394Malignant mesothelioma N = 277Testp
GenderMale, N (%)119 (68.0)271 (68.8)202 (72.9)1.757

calculated using Fisher exact test

0.410
Female, N (%)56 (32.0)123 (31.3)75 (27.1)
AgeMedian (25%–75%)55.3 (48.6–63.7)54.9 (48.8–62.7)66.0 (59.0–73.0)151.666

calculated using Kruskal-Wallis test

< 0.001
Low, N (%)134 (76.6)278 (71.6) [6]43 (48.3) [188]26.891

calculated using Fisher exact test

< 0.001
Asbestos exposureMedium, N (%)13 (7.4)41 (10.6)24 (27.0)
High, N (%)28 (16.0)69 (17.8)22 (24.7)
SmokingNo, N (%)94 (53.7)194 (49.4) [1]150 (55.6) [7]2.640

calculated using Fisher exact test

0.267
Yes, N (%)81 (46.3)199 (50.6)120 (44.4)

Association between selected polymorphisms and the risk of developing malignant mesothelioma

SNPGenotypeControls N (%)MM N (%)OR (95% CI)pOR (95% CI)adj1padj1OR (95% CI)adj2padj2
IL1B rs1143623GG88 (50.3)152 (54.9)referencereference
GC67 (38.3)97 (35.0)0.84 (0.56–1.26)0.3960.82 (0.52–1.29)0.3880.56 (0.29–1.05)0.072
CC20 (11.4)28 (10.1)0.81 (0.43–1.52)0.5140.69 (0.35–1.38)0.2940.34 (0.11–1.04)0.060
GC+CC87 (49.7)125 (45.1)0.83 (0.57–1.22)0.3410.79 (0.52–1.20)0.2660.50 (0.28–0.92)0.025
IL1B rs16944TT21 (12.0)36 (13.0)1.10 (0.60–2.02)0.7560.94 (0.48–1.82)0.8490.53 (0.20–1.43)0.210
TC75 (42.9)118 (42.6)1.01 (0.67–1.51)0.9600.98 (0.63–1.52)0.9110.67 (0.36–1.24)0.198
CC79 (45.1)123 (44.4)referencereference
TC+TT96 (54.9)154 (55.6)1.03 (0.70–1.51)0.8780.97 (0.64–1.47)0.8730.63 (0.35–1.13)0.122
IL1B rs1071676GG105 (60.0)165 (59.6)referencereference
GC60 (34.3)98 (35.4)1.04 (0.69–1.56)0.8510.97 (0.62–1.51)0.8951.00 (0.53–1.89)0.993
CC10 (5.7)14 (5.1)0.89 (0.38–2.08)0.7890.96 (0.38–2.41)0.9312.03 (0.70–5.90)0.194
GC+CC70 (40.0)112 (40.4)1.02 (0.69–1.50)0.9270.97 (0.64–1.48)0.8851.15 (0.64–2.08)0.632
MIR146A rs2910164GG94 (53.7)158 (57.0)referencereference
GC64 (36.6)110 (39.7)1.02 (0.69–1.53)0.9130.91 (0.59–1.41)0.6720.67 (0.36–1.25)0.209
CC17 (9.7)9 (3.2)0.31 (0.13–0.73)0.0080.34 (0.14–0.85)0.0200.39 (0.11–1.38)0.144
GC+CC81 (46.3)119 (43.0)0.87 (0.60–1.28)0.4880.79 (0.52–1.21)0.2780.62 (0.34–1.11)0.109
DOI: https://doi.org/10.2478/raon-2020-0057 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 429 - 436
Submitted on: Jul 7, 2020
|
Accepted on: Aug 6, 2020
|
Published on: Oct 21, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Petra Piber, Neza Vavpetic, Katja Goricar, Vita Dolzan, Viljem Kovac, Alenka Franko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.